30
Participants
Start Date
March 30, 2019
Primary Completion Date
March 30, 2020
Study Completion Date
March 30, 2021
innovative nutraceutical-type food product that we designed called HIC1® from coffee mucilage
All participants completed a survey on sociodemographic data (age, sex, respiratory problems, smoking, among others). Weight, height, skin folds, and a blood sample were taken to quantify the Oxygen Radical Absorption Capacity (ORAC) units, amino acids, vitamin B12, vitamin D, phosphorus, magnesium, calcium, and lipid profile. At that time, they were explained how they should eat the nutraceutical food, starting the next day and for five consecutive days. During those 5 days, a nurse made contact calls to verify that the participant took the corresponding dose for the day. After 5 days of ingesting the nutraceutical compound, a blood sample was taken again to quantify post-ingestion levels of ORAC units, amino acids, vitamin B12, vitamin D, phosphorus, magnesium, calcium, and the lipid profile. In the case of the participants in the ICU, control visits were made to the unit to verify that the dose was delivered to the participant
Fundación Cardiovascular de Colombia, Floridablanca
Sanadores Ambientales SANAM Company SAS
UNKNOWN
Fundación Cardiovascular de Colombia
OTHER